Complete ICD-10-CM coding and documentation guide for Close Contact with Quantiferon Positive. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Complete code families applicable to Close Contact with Quantiferon Positive
Contact with and (suspected) exposure to communicable diseases
This range includes codes for contact with and exposure to communicable diseases, including tuberculosis.
Other abnormal immunological findings in serum
This range includes codes for nonspecific reactions to tests for tuberculosis, such as a positive Quantiferon test.
Compare key differences between these codes to ensure accurate selection
Code | Description | When to Use | Key Documentation |
---|---|---|---|
Z20.1 | Contact with and (suspected) exposure to tuberculosis | Use when the patient is being evaluated due to exposure to a confirmed TB case. |
|
R76.12 | Nonspecific reaction to cell-mediated immunity measurement of gamma interferon antigen response without active tuberculosis | Use when the Quantiferon test is positive, but active TB is ruled out. |
|
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Essential facts and insights about Close Contact with Quantiferon Positive
Use when the Quantiferon test is positive, but active TB is ruled out.
Ensure test results and absence of active TB symptoms are documented.
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Encounter for testing for latent tuberculosis infection
Z11.7Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Avoid these common documentation and coding issues when documenting Close Contact with Quantiferon Positive to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code Z20.1.
Clinical: May lead to unnecessary treatment or follow-up., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials.
Ensure thorough documentation of symptom assessment.
Reimbursement: Incorrect sequencing can lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate data on TB exposure and testing.
Sequence Z20.1 as the primary code when the encounter is due to exposure.
Using R76.12 as primary when Z20.1 should be primary.
Review coding guidelines for proper sequencing.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Common questions about ICD-10 coding for Close Contact with Quantiferon Positive, with expert answers to help guide accurate code selection and documentation.
Use these documentation templates to ensure complete and accurate documentation for Close Contact with Quantiferon Positive. These templates include all required elements for proper coding and billing.
Need help with ICD-10 coding for Close Contact with Quantiferon Positive? Ask your questions below.